Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells are a heterogeneous group of professional antigen-presenting cells present in tissues throughout the body[1][2][3][4]. They capture, process, and display antigens to T lymphocytes via MHC molecules, serving as sentinels that bridge innate and adaptive immunity. Dendritic cells play an essential role in initiating immune responses, maintaining tolerance to self-antigens, and secreting cytokines/chemokines that coordinate immune responses. Their activity is crucial for effective immunity against pathogens and tumors, but also for regulating inflammation and preventing autoimmunity[1][2][3][4][5].
Drugs that affect dendritic cells usually work by: - Promoting differentiation or expansion of DCs (e.g., cytokines) - Enhancing antigen presentation (e.g., vaccine adjuvants) - Modulating DC activation/maturation state (immunotherapies) - Inducing DC-mediated immune tolerance (investigational approaches)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell (antigen-presenting) (DC (full context: antigen-presenting dendritic cell)).